Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study
出版年份 2021 全文链接
标题
Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study
作者
关键词
-
出版物
BMC Pulmonary Medicine
Volume 21, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-05-16
DOI
10.1186/s12890-021-01530-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Surfactant protein A as a biomarker of outcomes of anti-fibrotic drug therapy in patients with idiopathic pulmonary fibrosis
- (2020) Takumi Yoshikawa et al. BMC Pulmonary Medicine
- Recent progress on surfactant protein A: cellular function in lung and kidney disease development
- (2020) Skylar D. King et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Krebs von den Lungen-6 as a biomarker for disease severity assessment in interstitial lung disease: a comprehensive review
- (2020) Miriana d’Alessandro et al. Biomarkers in Medicine
- Subgroup Analysis for Chinese Patients Included in the INPULSIS® Trials on Nintedanib in Idiopathic Pulmonary Fibrosis
- (2019) Zuojun Xu et al. ADVANCES IN THERAPY
- Clinical Pharmacokinetics and Pharmacodynamics of Nintedanib
- (2019) Sven Wind et al. CLINICAL PHARMACOKINETICS
- Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease
- (2019) Oliver Distler et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and tolerability of nintedanib in patients with IPF in the United States
- (2018) Imre Noth et al. EUROPEAN RESPIRATORY JOURNAL
- Pharmacogenomics of drug-induced liver injury (DILI): Molecular biology to clinical applications
- (2018) Kalaiyarasi Kaliyaperumal et al. JOURNAL OF HEPATOLOGY
- Idiopathic Pulmonary Fibrosis
- (2018) David J. Lederer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and efficacy of nintedanib in idiopathic pulmonary fibrosis: A real-life observational study in Greece
- (2018) Argyrios Tzouvelekis et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Real-World Experience with Nintedanib in Patients with Idiopathic Pulmonary Fibrosis
- (2018) Eva Brunnemer et al. RESPIRATION
- A Real-Life Multicenter National Study on Nintedanib in Severe Idiopathic Pulmonary Fibrosis
- (2018) Sergio Harari et al. RESPIRATION
- Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
- (2018) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON
- (2018) Bruno Crestani et al. Lancet Respiratory Medicine
- Utility of nintedanib for severe idiopathic pulmonary fibrosis: a single-center retrospective study
- (2018) Mitsuhiro Abe et al. Drug Design Development and Therapy
- Pirfenidone and Nintedanib in idiopathic pulmonary fibrosis: Real-life experience in an Italian referral centre
- (2018) E. Bargagli et al. Pulmonology
- Pharmacokinetics of Nintedanib in Subjects With Hepatic Impairment
- (2017) Kristell Marzin et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Pirfenidone and nintedanib for pulmonary fibrosis in clinical practice: Tolerability and adverse drug reactions
- (2017) Jonathan A. Galli et al. RESPIROLOGY
- Low body surface area predicts hepatotoxicity of nintedanib in patients with idiopathic pulmonary fibrosis
- (2017) Satoshi Ikeda et al. Scientific Reports
- Efficacy of Nintedanib in Idiopathic Pulmonary Fibrosis across Prespecified Subgroups in INPULSIS
- (2016) Ulrich Costabel et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report
- (2016) Harold R. Collard et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Insights from the German Compassionate Use Program of Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis
- (2016) Francesco Bonella et al. RESPIRATION
- Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS® trials
- (2016) Luca Richeldi et al. RESPIRATORY MEDICINE
- Subgroup analysis of Asian patients in the INPULSIS®trials of nintedanib in idiopathic pulmonary fibrosis
- (2016) Hiroyuki Taniguchi et al. RESPIROLOGY
- Nintedanib in Japanese patients with idiopathic pulmonary fibrosis: A subgroup analysis of the INPULSIS® randomized trials
- (2016) Arata Azuma et al. RESPIROLOGY
- Real World Experiences: Pirfenidone and Nintedanib are Effective and Well Tolerated Treatments for Idiopathic Pulmonary Fibrosis
- (2016) Gareth Hughes et al. Journal of Clinical Medicine
- Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE)
- (2016) Andriana I. Papaioannou et al. PLoS One
- Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
- (2015) Lutz Wollin et al. EUROPEAN RESPIRATORY JOURNAL
- Idiopathic pulmonary fibrosis: Diagnosis, epidemiology and natural history
- (2015) Giacomo Sgalla et al. RESPIROLOGY
- Molecular biomarkers in idiopathic pulmonary fibrosis
- (2014) Brett Ley et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
- (2014) Talmadge E. King et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
- (2014) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Baseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosis
- (2014) Shinichiro Ohshimo et al. RESPIRATORY MEDICINE
- A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis
- (2013) Brett Ley et al. ANNALS OF INTERNAL MEDICINE
- Blood Biomarkers MMP-7 and SP-A
- (2013) Jin Woo Song et al. CHEST
- Acute exacerbations in patients with idiopathic pulmonary fibrosis
- (2013) Dong Kim RESPIRATORY RESEARCH
- Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year prospective study
- (2012) Marco Mura et al. EUROPEAN RESPIRATORY JOURNAL
- Idiopathic pulmonary fibrosis in Taiwan – A population-based study
- (2012) Chih-Cheng Lai et al. RESPIRATORY MEDICINE
- Different MUC1 gene polymorphisms in German and Japanese ethnicities affect serum KL-6 levels
- (2012) Yasushi Horimasu et al. RESPIRATORY MEDICINE
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
- (2011) Ganesh Raghu et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Case Definition and Phenotype Standardization in Drug-Induced Liver Injury
- (2011) G P Aithal et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Idiopathic pulmonary fibrosis
- (2011) Talmadge E King et al. LANCET
- Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
- (2011) Luca Richeldi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology
- (2010) C. Vancheri et al. EUROPEAN RESPIRATORY JOURNAL
- Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis
- (2009) C. J. Zappala et al. EUROPEAN RESPIRATORY JOURNAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now